IL-27 signalling and its role in limiting Th1 cell-mediated inflammation has been reported in many experimental settings, including, encephalomyelitis [58], inflammatory bowel disease [59], tuberculosis [60], trypanosomiasis [61], malaria [20] and leishmaniasis [5]. This evidence concerns the gene IL27 and leishmaniasis.